Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity

Creative Commons License

Gunay M., ÇELİK G., Gunay B. O., AKTAŞ A., KARATEKİN G., Ovali F.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, cilt.78, sa.5, ss.300-304, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5935/0004-2749.20150079
  • Dergi Adı: ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.300-304
  • Anahtar Kelimeler: Bevacizumab, Intravitreal injections, Laser therapy, Retinopathy of prematurity, Treatment outcomes, ENDOTHELIAL GROWTH-FACTOR, THRESHOLD RETINOPATHY, LASER PHOTOCOAGULATION, PRETHRESHOLD RETINOPATHY, RETINAL-DETACHMENT, REFRACTIVE ERROR, CRYOTHERAPY, INFANTS, MONOTHERAPY, TRIAL
  • Karadeniz Teknik Üniversitesi Adresli: Hayır

Özet

Purpose: To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).